Abstract Guidelines
| Standard Guidelines for Preparing Abstracts MWAOAC Section Meeting Deadline: April 18, 2008 |
An Abstract must be submitted for all papers and presentations. Abstracts should be
submitted by the deadlines specified and should adhere to the specific guidelines
listed below.
submitted by the deadlines specified and should adhere to the specific guidelines
listed below.
Abstract Guidelines
- Abstracts are due to the session chair by April 18, 2008.
- Include the title of the presentation.
- Provide the primary author’s full name, title, affiliation,
complete mailing address, phone number and email
address. - Include the full name, affiliation, city, state, and country
for all co-authors, if applicable.
Abstract body (excluding title and authors) should be no longer than 150 words. Text
should be provided in Times New Roman font. Graphs and charts will not be
accepted. The abstract should begin with the reason for the work and include as much
concrete information as possible. Emphasize novel features. Generalities such as
"...results will be discussed..." should be avoided. Commercial content is NOT
acceptable for abstracts or presentations, and logos and similar content should not be
included.
should be provided in Times New Roman font. Graphs and charts will not be
accepted. The abstract should begin with the reason for the work and include as much
concrete information as possible. Emphasize novel features. Generalities such as
"...results will be discussed..." should be avoided. Commercial content is NOT
acceptable for abstracts or presentations, and logos and similar content should not be
included.
Sample Abstract Format
Socrates Trujillo, Henry Njapau, Benjamin J. Canas, Douglas L. Park, U.S Food and
Drug Administration, College Park, MD, USA; Nicholas Fico, University of Maryland,
College Park, MD, USA
Single Laboratory Validation of Commercially Available Kits for the Detection of
Aflatoxin M1
(Abstract text – up to 150 words)
Socrates Trujillo, Interdisciplinary Scientist, U.S. Food and Drug Administration
CFSAN, HFS 345, 5100 Paint Branch Parkway, College Park, MD 20740-3835, USA,
Phone: 301-436-2037, Email: Socrates.trujillo@fda.hhs.gov
Drug Administration, College Park, MD, USA; Nicholas Fico, University of Maryland,
College Park, MD, USA
Single Laboratory Validation of Commercially Available Kits for the Detection of
Aflatoxin M1
(Abstract text – up to 150 words)
Socrates Trujillo, Interdisciplinary Scientist, U.S. Food and Drug Administration
CFSAN, HFS 345, 5100 Paint Branch Parkway, College Park, MD 20740-3835, USA,
Phone: 301-436-2037, Email: Socrates.trujillo@fda.hhs.gov
The primary author should submit the abstract directly to the appropriate
session chair.
session chair.